PAN-TB regimens to address growing TB drug resistance
By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly…
March 24, 2023 - 5 minutes
External Contributor
Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.
Should pharma be listening to social media to drive drug development?
By Thierry Escudier, consultant and strategic leader at The Pistoia Alliance The move towards patient…
March 8, 2023 - 5 minutes
5 steps to strategic partnerships for healthtech startups
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way…
March 2, 2023 - 6 minutes
Life changing treatments for rare disease – a beacon of hope
By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are…
February 28, 2023 - 6 minutes
Five things you need to know about using CRISPR/Cas9 commercially
By Michael Arciero, vice president of intellectual property and corporate development, ERS Genomics Michael Arciero,…
February 16, 2023 - 6 minutes
How AI and ML can transform clinical research
By Gary Shorter, head of artificial intelligence at IQVIA Clinical trials are currently in an…
February 9, 2023 - 4 minutes
AI and experiments: new possibilities emerge in 2023
By Markus Gershater, co-founder and chief scientific officer, Synthace The buzz surrounding generative AI has…
February 3, 2023 - 5 minutes
How digital biomarker assays can harness the power of deep learning from clinical trials to the clinic
By Joe Oakley, MD, medical director of biomarker development, Paige Just as much of medicine…
February 2, 2023 - 8 minutes
The future of cancer treatment: Exploiting cancer’s key vulnerabilities
By Victoria Zazulina, M.D., head of development unit, oncology, for the healthcare business of Merck…
February 1, 2023 - 4 minutes
Expanding the world of biomarkers with proteogenomics
By Michael Pisano, executive vice president, proteomics, Discovery Life Sciences In oncology, characterizing genetic markers…
February 1, 2023 - 7 minutes
Next-generation small molecules hold promise for immunotherapy
By Ian B. Walters, chief executive officer and chairman, Portage Biotech In recent years, PD-1/PD-L1…
February 1, 2023 - 3 minutes
Advancing cancer care with 3D genomics
By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the…
February 1, 2023 - 7 minutes
